These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 18519680)

  • 21. A quantitative analysis of N-myc downstream regulated gene 2 (NDRG 2) in human tissues and cell lysates by reverse-phase protein microarray.
    Park MY; Choi SC; Lee HS; Kim D; Baek KE; Kim JT; Lim JS; Yeom YI; Chung JW; Kim JW; Myung PK; Lee HG; Kim JW; Song EY
    Clin Chim Acta; 2008 Jan; 387(1-2):84-9. PubMed ID: 17936257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycolysis module activated by hypoxia-inducible factor 1alpha is related to the aggressive phenotype of hepatocellular carcinoma.
    Hamaguchi T; Iizuka N; Tsunedomi R; Hamamoto Y; Miyamoto T; Iida M; Tokuhisa Y; Sakamoto K; Takashima M; Tamesa T; Oka M
    Int J Oncol; 2008 Oct; 33(4):725-31. PubMed ID: 18813785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic inactivation of protein kinase D1 in gastric cancer and its role in gastric cancer cell migration and invasion.
    Kim M; Jang HR; Kim JH; Noh SM; Song KS; Cho JS; Jeong HY; Norman JC; Caswell PT; Kang GH; Kim SY; Yoo HS; Kim YS
    Carcinogenesis; 2008 Mar; 29(3):629-37. PubMed ID: 18283041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NDRG2 correlated with favorable recurrence-free survival inhibits metastasis of mouse breast cancer cells via attenuation of active TGF-β production.
    Oh SS; Kim D; Kim DH; Chang HH; Sohn KC; Kim KH; Jung SH; Lee BK; Kim JH; Kim KD
    Carcinogenesis; 2012 Oct; 33(10):1882-8. PubMed ID: 22696597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of invasion and metastasis of prostate cancer cells by overexpression of NDRG2 gene.
    Gao L; Wu GJ; Liu XW; Zhang R; Yu L; Zhang G; Liu F; Yu CG; Yuan JL; Wang H; Yao LB
    Cancer Lett; 2011 Nov; 310(1):94-100. PubMed ID: 21741166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Down-regulation of NDRG2 gene expression in human colorectal cancer involves promoter methylation and microRNA-650.
    Feng L; Xie Y; Zhang H; Wu Y
    Biochem Biophys Res Commun; 2011 Mar; 406(4):534-8. PubMed ID: 21352815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Expression and significance of new candidate tumor suppressor gene N-Myc downstream-regulated gene 2 in colorectal cancer].
    Shi H; Wang WZ; Yao LB; Zhang J; Yin Q; Xu CS; Chu DK; Dong GL; Zhang HW; Li JP
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 May; 12(3):281-4. PubMed ID: 19434539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery.
    Yang XR; Xu Y; Yu B; Zhou J; Li JC; Qiu SJ; Shi YH; Wang XY; Dai Z; Shi GM; Wu B; Wu LM; Yang GH; Zhang BH; Qin WX; Fan J
    Clin Cancer Res; 2009 Sep; 15(17):5518-27. PubMed ID: 19706825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction of PKC alpha decreases cell proliferation, migration, and invasion of human malignant hepatocellular carcinoma.
    Wu TT; Hsieh YH; Hsieh YS; Liu JY
    J Cell Biochem; 2008 Jan; 103(1):9-20. PubMed ID: 17486587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma.
    Lu B; Ma Y; Wu G; Tong X; Guo H; Liang A; Cong W; Liu C; Wang H; Wu M; Zhao J; Guo Y
    Clin Cancer Res; 2008 Nov; 14(22):7405-12. PubMed ID: 19010857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Periostin creates a tumor-supportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity.
    Erkan M; Kleeff J; Gorbachevski A; Reiser C; Mitkus T; Esposito I; Giese T; Büchler MW; Giese NA; Friess H
    Gastroenterology; 2007 Apr; 132(4):1447-64. PubMed ID: 17408641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expression and clinical significance of Ephrin-A1 in primary hepatocellular carcinoma].
    Zhang G; Zhang SJ; Zhao YF; Wu Y; Li Z; Wang JX
    Zhonghua Wai Ke Za Zhi; 2007 Apr; 45(7):499-502. PubMed ID: 17686315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lysyl oxidase like 4, a novel target gene of TGF-beta1 signaling, can negatively regulate TGF-beta1-induced cell motility in PLC/PRF/5 hepatoma cells.
    Kim DJ; Lee DC; Yang SJ; Lee JJ; Bae EM; Kim DM; Min SH; Kim SJ; Kang DC; Sang BC; Myung PK; Park KC; Yeom YI
    Biochem Biophys Res Commun; 2008 Sep; 373(4):521-7. PubMed ID: 18586005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased expression of KAI1/CD82 metastasis suppressor gene is associated with loss of heterozygosity in melanoma cell lines.
    Kim YI; Shin MK; Lee JW; Chung JH; Lee MH
    Oncol Rep; 2009 Jan; 21(1):159-64. PubMed ID: 19082457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
    Moore LD; Isayeva T; Siegal GP; Ponnazhagan S
    Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expression of vascular endothelial growth factor (VEGF) family members and prognosis after hepatic resection in HBV-related hepatocellular carcinoma].
    Moon JI; Kim JM; Jung GO; Chun JM; Choi GS; Park JB; Kwon CH; Kim SJ; Jo JW
    Korean J Hepatol; 2008 Jun; 14(2):185-96. PubMed ID: 18617766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased expression of inhibitor of growth 4 correlated with poor prognosis of hepatocellular carcinoma.
    Fang F; Luo LB; Tao YM; Wu F; Yang LY
    Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):409-16. PubMed ID: 19208663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased ID2 promotes metastatic potentials of hepatocellular carcinoma by altering secretion of vascular endothelial growth factor.
    Tsunedomi R; Iizuka N; Tamesa T; Sakamoto K; Hamaguchi T; Somura H; Yamada M; Oka M
    Clin Cancer Res; 2008 Feb; 14(4):1025-31. PubMed ID: 18281534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative proteomic signature of liver cancer cells: tissue transglutaminase 2 could be a novel protein candidate of human hepatocellular carcinoma.
    Sun Y; Mi W; Cai J; Ying W; Liu F; Lu H; Qiao Y; Jia W; Bi X; Lu N; Liu S; Qian X; Zhao X
    J Proteome Res; 2008 Sep; 7(9):3847-59. PubMed ID: 18646787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinoma.
    Wong CM; Yam JW; Ching YP; Yau TO; Leung TH; Jin DY; Ng IO
    Cancer Res; 2005 Oct; 65(19):8861-8. PubMed ID: 16204057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.